This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:

Sanofi Reports the P-II Study Data of Frexalimab for the Treatment of Multiple Sclerosis

Read More: Sanofi

AstraZeneca Reports the EMA’s Acceptance of MAA for Sipavibart Under Accelerated Assessment to Prevent COVID-19

Read More: AstraZeneca

Ipsen Reports Collaboration Expansion with Exelixis to Develop Cabometyx for Treating Neuroendocrine Tumors

Read More: Ipsen & Exelixis

HOOKIPA Reports the First Patient Dosing in P-Ib Study of HB-500 to Treat HIV

Read More: HOOKIPA

Roche Reports P-II/III (SKYSCRAPER-06) Trial Data of Tiragolumab to Treat Non-Squamous Non-Small Cell Lung Cancer

Read More: Roche

Zhejiang Doer Biologics Concludes Patient Recruitment in P-Ib/IIa Study of DR10624 Among Obese Individuals

Read More: Zhejiang Doer Biologics

Roche Reports the CHMP’s Positive Opinion of Vabysmo for Retinal Vein Occlusion (RVO)

Read More: Roche

AbbVie’s Tepkinly (Epcoritamab) Gains the CHMP’s Positive Opinion to Treat R/R Follicular Lymphoma

Read More: AbbVie

AstraZeneca’s Lynparza Plus Imfinzi Receives the CHMP’s Positive Opinion for Treating Endometrial Cancer

Read More: AstraZeneca

Eli Lilly Reports the US FDA’s Approval of Kisunla (donanemab-azbt) to Treat Early Symptomatic Alzheimer's Disease

Read More: Eli Lilly

Regeneron and Sanofi Report the EC’s Approval of Dupixent to Treat Chronic Obstructive Pulmonary Disease (COPD)

Read More: Regeneron & Sanofi

Johnson & Johnson’s Sirturo Gains the US FDA & EC’s Approval to Treat Pulmonary Tuberculosis

Read More: Johnson & Johnson

HUTCHMED Reports the NMPA’s NDA Acceptance of Tazemetostat for Treating Follicular Lymphoma

Read More: HUTCHMED

Full-Life Technologies’ 225Ac-FL-020 Gains the US FDA’s Fast Track Designation to Treat Metastatic Castration-Resistant Prostate Cancer

Read More: Full-Life Technologies

Medigene Receives Chinese Patent for MDG1015 to Treat Various Solid Tumors

Read More: Medigene

Roche’s Vabysmo Prefilled Syringe Receives the US FDA’s Approval for Vision Loss

Read More: Roche

AstraZeneca’s Tagrisso Plus Chemotherapy Receives the EC’s Approval to Treat EGFR-Mutated Advanced Lung Cancer

Read More: AstraZeneca

Eleva’s CPV-104 Gains EC’s Orphan Drug Designation to Treat C3 Glomerulopathy (C3G)

Read More: Eleva

Biostar Pharma Reports the US FDA’s IND Clearance for P-II Trial of Utidelone to Treat Breast Cancer Brain Metastasis

Read More: Biostar Pharma                   

Ubix Therapeutics Collaborates with Yuhan to Develop UBX-103 for Treating Metastatic Castration Resistant Prostate Cancer

Read More: Ubix Therapeutics & Yuhan

Radionetics Oncology and Eli Lilly Collaborate to Develop Small Molecule Radiopharmaceuticals

Read More: Radionetics & Eli Lilly

GSK and CureVac Report Restructuring of their Partnership

Read More: GSK & CureVac

Ascentage Pharma Obtains an Option Payment of $100M from Takeda

Read More: Ascentage & Takeda

Pendopharm Collaborates with Ascendis Pharma to Commercialize TransCon PTH for Treating Hypoparathyroidism in Canada

Read More: Pendopharm & Ascendis Pharma

Samsung Bioepis Reports the US FDA’s Approval of Pyzchiva (Biosimilar, Stelara)

Read More: Samsung Bioepis

Kashiv BioSciences Partners with Amneal Pharmaceuticals to Commercialize ADL018 (Biosimilar, Xolair)

Read More: Kashiv BioSciences & Amneal Pharmaceuticals

Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)

Read More: Alvotech

Formycon and Klinge Biopharma Reports the US FDA’s Approval of Ahzantive (Biosimilar, Eylea)

Read More: Formycon & Klinge Biopharma

Tanvex BioPharma Reports the US FDA’s Approval of Nypozi (Biosimilar, Neupogen)

Read More: Tanvex

Can-Fite Reports Data from its Partner Vetbiolix’s Clinical Study of Piclidenoson in Dogs with Osteoarthritis

Read More: Can-Fite

Pentixapharm Reports the Acquisition of Glycotope’s Target Discovery Business

Read More: Pentixapharm & Glycotope

Quest Diagnostics Reports the Acquisition of LifeLabs from OMERS for an Aggregate of ~$985M

Read More: Quest Diagnostics

Related Post: PharmaShots Weekly Snapshots (June 24 – June 28, 2024)